A repository & source of cutting edge news about emerging terahertz technology, it's commercialization & innovations in THz devices, quality control, process control, medical diagnostics, security, astronomy, communications, graphene, metamaterials, CMOS, compressive sensing, 3d printing, and the Internet of Nanothings. NOTHING POSTED IS INVESTMENT ADVICE! REPOSTED COPYRIGHT IS FOR EDUCATIONAL USE.
Wednesday, April 13, 2016
FDA solicts terahertz spectrometer- FDASOL1161829 for analytical laboratory instrument manufacturing at Food and Drug Administration Office of Acquisitions and Grants Services - Rockville, response due Apr 20, 2016.
The U.S. Food and Drug Administration's (FDA) Center for Drug Evaluation and Research (CDER) has a need for a new terahertz spectrometer with the capability to analyze tablet and capsule form dosage forms and providing information such as polymorphic form characterization. This type of information has traditionally only been available when running crystallographic methods. This purchase is intended to upgrade the capabilities currently held at the Division of Pharmaceutical Analysis and to support important projects such as spectral library and screening activities that are part of an effort to improve efficiency and increase sample throughput.